Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Buy
+18,059
New +$807K 0.02% 539
2025
Q2
Sell
-16,219
Closed -$900K 1555
2025
Q1
$900K Buy
+16,219
New +$878K 0.04% 434
2024
Q4
Sell
-103,909
Closed -$5.99M 3652
2024
Q3
$5.99M Buy
103,909
+78,743
+313% +$4.25M 0.01% 777
2024
Q2
$1.22M Buy
25,166
+17,169
+215% +$828K ﹤0.01% 1886
2024
Q1
$389K Sell
7,997
-32,649
-80% -$1.59M ﹤0.01% 2787
2023
Q4
$2.02M Buy
40,646
+24,102
+146% +$1.18M ﹤0.01% 1644
2023
Q3
$887K Buy
16,544
+5,256
+47% +$280K ﹤0.01% 2110
2023
Q2
$608K Buy
+11,288
New +$607K 0.02% 589

Other funds holding SNY

GTS Securities's SNY Position: Q2 2026 in Review

GTS Securities opened a new position in Sanofi (SNY) in Q2 2026: 18,059 shares worth $770K. The stake represents 0.02% of the portfolio and ranks #539 among its holdings. This is a return to the name: GTS Securities previously reported a position in SNY as recently as Q1 2025.

GTS Securities first reported a position in SNY in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.99M in Q3 2024. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • GTS Securities held 18,059 shares of Sanofi worth $770K as of Q2 2026.
  • Sanofi was a new GTS Securities position in Q2 2026.
  • Sanofi made up 0.02% of GTS Securities's portfolio in Q2 2026, its #539 holding.
  • GTS Securities first reported a position in Sanofi in Q2 2023 and has held it in 8 quarters since.
  • GTS Securities's Sanofi position peaked at $5.99M in Q3 2024.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.